BioMarin Pharmaceutical Inc. - Strategy and SWOT Report,
- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Features:
- Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on BioMarin Pharmaceutical Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:BioMarin Pharmaceutical (BioMarin or 'the company'), a commercial-stage biopharmaceutical company, develops and commercializes biopharmaceuticals for the treatment of serious diseases and medical conditions. The company operates in the US, Europe and Latin America. It is headquartered in San Rafael, California, and employed 1,341 people as of January 24, 2014.
Reasons to Purchase:Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies Track strategic initiatives of the company and latest corporate news and actions Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplierSupport sales activities by understanding your customers' businesses betterStay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects
- Company Snapshot
- BioMarin Pharmaceutical Inc.: Company Overview
- BioMarin Pharmaceutical Inc.: Overview and Key Facts
- BioMarin Pharmaceutical Inc.: Overview
- BioMarin Pharmaceutical Inc.: Key Facts
- BioMarin Pharmaceutical Inc.: Key Employees
- BioMarin Pharmaceutical Inc.: Key Employee Biographies
- BioMarin Pharmaceutical Inc.: Major Products and Services
- BioMarin Pharmaceutical Inc.: Company History
- BioMarin Pharmaceutical Inc.: Management Statement
- BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
- BioMarin Pharmaceutical Inc.: Key Competitors
- BioMarin Pharmaceutical Inc.: Company Analysis
- BioMarin Pharmaceutical Inc.: Business Description
- BioMarin Pharmaceutical Inc.: SWOT Analysis
- BioMarin Pharmaceutical Inc.: SWOT Overview
- BioMarin Pharmaceutical Inc.: Strengths
- BioMarin Pharmaceutical Inc.: Weaknesses
- BioMarin Pharmaceutical Inc.: Opportunities
- BioMarin Pharmaceutical Inc.: Threats
- BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity
- BioMarin Pharmaceutical Inc.: Financial Deals Overview
- BioMarin Pharmaceutical Inc.: Targets and Partners
- BioMarin Pharmaceutical Inc.: Top Deals 2011 - 2015YTD*
- BioMarin Pharmaceutical Inc.: Advisors
- BioMarin Pharmaceutical Inc.: Top Legal Advisors
- BioMarin Pharmaceutical Inc.: Top Financial Advisors
- BioMarin Pharmaceutical Inc.: Mergers and Acquisitions
- BioMarin Pharmaceutical Inc.: Corporate Venturing
- BioMarin Pharmaceutical Inc.: Capital Raising
- BioMarin Pharmaceutical Inc.: Partnership
- BioMarin Pharmaceutical Inc.: Recent Developments
- BioMarin Pharmaceutical Inc.: News and Events Summary
- BioMarin Pharmaceutical Inc.: Contracts
- BioMarin Pharmaceutical Inc.: Corporate Governance
- BioMarin Pharmaceutical Inc.: Financial Performance
- BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
- BioMarin Pharmaceutical Inc.: Research & Development
- Appendix
- Contact Us
- Methodology
- Definitions
- About Market Line
- List of Tables
- Table 1: BioMarin Pharmaceutical Inc.: Key Facts
- Table 2: BioMarin Pharmaceutical Inc.: Key Employees
- Table 4: BioMarin Pharmaceutical Inc.: Key Competitors
- Table 5: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM*)
- Table 7: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
- Table 8: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
- Table 9: BioMarin Pharmaceutical Inc.: Targets and Partners
- Table 10: BioMarin Pharmaceutical Inc.: Top Deals 2011 - 2015YTD*
- Table 11: BioMarin Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
- Table 12: BioMarin Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
- Table 13: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
- Table 14: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2011 - YTD*2015)
- Table 15: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
- Table 16: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2011 - YTD*2015)
- Table 17: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
- Table 18: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
- Table 19: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
- Table 20: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
- Table 21: BioMarin Pharmaceutical Inc.: News and Events Summary
- Table 22: BioMarin Pharmaceutical Inc.: Contracts
- Table 23: BioMarin Pharmaceutical Inc.: Corporate Governance
- Table 24: BioMarin Pharmaceutical Inc.: Financial Performance
- Table 25: BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
- Table 26: BioMarin Pharmaceutical Inc.: Research & Development
- List of Figures
- Figure 1: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM*)
- Figure 3: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
- Figure 4: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
- Figure 5: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
- Figure 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2011 - YTD*2015)
- Figure 7: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
- Figure 8: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2011 - YTD*2015)
- Figure 9: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
- Figure 10: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
- Figure 11: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
- Figure 12: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)